| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,744 |
2,436 |
$134K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,376 |
1,213 |
$88K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,065 |
1,008 |
$66K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
379 |
353 |
$37K |
| 92567 |
|
557 |
540 |
$6K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
76 |
73 |
$6K |
| 81514 |
|
20 |
19 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
1,412 |
1,330 |
$4K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
52 |
50 |
$4K |
| 87510 |
|
173 |
158 |
$4K |
| 87480 |
|
173 |
158 |
$4K |
| 87660 |
|
173 |
158 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
78 |
76 |
$3K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
76 |
73 |
$3K |
| 87481 |
|
76 |
73 |
$3K |
| 92557 |
|
109 |
106 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
32 |
32 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
49 |
46 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
114 |
108 |
$2K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
18 |
17 |
$2K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
12 |
12 |
$1K |
| 85027 |
|
166 |
160 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
27 |
27 |
$1K |
| 86780 |
|
60 |
60 |
$883.49 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
32 |
32 |
$800.00 |
| 86850 |
|
57 |
57 |
$577.36 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
83 |
75 |
$395.73 |
| 73610 |
|
13 |
12 |
$379.89 |
| 90686 |
|
30 |
29 |
$369.32 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
35 |
25 |
$345.07 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
12 |
12 |
$339.72 |
| 20610 |
|
128 |
54 |
$312.27 |
| 82950 |
|
12 |
12 |
$55.88 |
| 81003 |
|
12 |
12 |
$18.72 |
| 99000 |
|
26 |
26 |
$0.00 |
| 90715 |
|
12 |
12 |
$0.00 |
| 59025 |
Fetal non-stress test |
20 |
13 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
15 |
14 |
$0.00 |